selective norepinephrine reuptake inhibitor

Mechanism of Action of Viloxazine

August 5, 2026 Harsh Singh Rajput

Introduction Viloxazine is an oral non-stimulant drug marketed under the brand name Qelbree. Pharmacologically, viloxazine is a selective norepinephrine reuptake inhibitor used in attention-deficit/hyperactivity disorder, commonly called ADHD. ADHD is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, impulsivity, or a combination of these symptoms. It can affect academic performance, work productivity, behavior, … Read more

Mechanism of Action of Atomoxetine

August 1, 2025 Harsh Singh Rajput

Introduction Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI) approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). It is a non-stimulant alternative to conventional stimulants like methylphenidate and amphetamines, especially beneficial for patients at risk of substance abuse or with contraindications to stimulants. Mechanism of Action (Stepwise) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature … Read more